AstraZeneca’s £19bn blow as Wainua heart drug fails key late-stage trial
AstraZeneca’s £19bn blow as Wainua heart drug fails key late-stage trial Proactive uses images sourced from Shutterstock AstraZeneca…
AstraZeneca’s £19bn blow as Wainua heart drug fails key late-stage trial
AstraZeneca’s £19bn blow as Wainua heart drug fails key late-stage trial Proactive uses images sourced from Shutterstock AstraZeneca…
Pfizer (PFE) Gets An Opening In ATTR CM After AstraZeneca Trial Failure
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
AstraZeneca Gets a Rare Clinical Black Eye
AstraZeneca Gets a Rare Clinical Black Eye – Moby THE GIST Our analysts just identified a stock with…
AstraZeneca’s Wainua Falls Short in Phase III ATTR-CM Study Despite Positive Subgroup Signal (AVG)
Astra Zeneca logo on building ©Adobe Stock Images AstraZeneca (LSE:AZN) and Ionis have announced that the Phase III…
BBIO Stock Surges 16% As AstraZeneca-Ionis Heart Drug Trial Misses Goal — BofA Calls Failure ‘A Big Surprise’
Analysts largely viewed the miss as a significant blow to Ionis but not fatal for the company overall.…
AstraZeneca’s Stock Drops on Wainua’s Setback in ATTR-CM Study
Shares of AstraZeneca AZN fell nearly 8% in pre-market trading today after the company announced the failure of…
Gene-Silencing Drug Wainua Fails Landmark ATTR-CM Trial in AstraZeneca Setback
AstraZeneca and Ionis Pharmaceuticals disclosed Thursday morning that their gene-silencing drug Wainua (eplontersen) failed the largest clinical trial…
AstraZeneca and Ionis’ stocks drop significantly on Wainua ATTR-CM trial failure
Both AstraZeneca and Ionis’ stocks took a hit at market open on 9 July after the companies announced…